NCT04393805View on ClinicalTrials.gov

Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto

CompletedOBSERVATIONAL
Enrollment

744

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

February 26, 2021

Study Completion Date

February 26, 2021

Conditions
COVID-19Hypercoagulability
Interventions
DRUG

Low Molecular Weight Heparin

Thromboprophylaxis with Low Molecular Weight Heparin, mostly enoxaparin

Trial Locations (1)

35138

Giuseppe Camporese, Padua

All Listed Sponsors
collaborator

University of Padova

OTHER

lead

Quovadis Associazione

OTHER

NCT04393805 - Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto | Biotech Hunter | Biotech Hunter